By: Gloria Gadea-Lopez, Ph.D. Director of Business Operations Management John Maguire Ass...
By: Karen Zink McCullough, MMI Associates Radhakrishna Tirumalai, Ph.D., United States ...
By: Dr. Dave Elder, PHD and Consultant David P Elder Consultancy
By: Jiayi Zhang, Manager, Process Development/Engineering Gregory Walsh, Associate Dire...
GE Healthcare Life Sciences
Barbara Paldus, PhD | CEO and co-founder, Finesse Solutions, Inc., Santa Clara, CA
Perfusion Cell Culture Processes: WuXi’s experience from China | WuXi Biologics sees an opportunity to start with a clean slate
Dr Nick Hutchinson (Technical Content Marketing Manager at Sartorius Stedim Biotech)
Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer
Presented by Dr Christine P. Chan, Ph.D., Sanofi. Followed by Joe Barco, Unchained Labs
28th March 2017
Presented by Gloria Gadea-Lopez & John Maguire
04th April 2017
Presented by Dr. Jonas Hoeg Thygesen, Novo Nordisk Pharmatech. Followed by Colin Merrifield, ProteinSimple
23rd February 2017
Presented by Dr. Carsten Timpe and Dr. Paolo Gatti
22nd April 2015
Presented by Mark Gibson
21st August 2013
Presented by Dr Joachim Walter
18th September 2013